Barclays »

Trevi Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $86k 64k 1.35
2023-09-30 $29k 13k 2.18
2023-06-30 $34k 14k 2.42
2021-09-30 $0 100 0.00
2021-06-30 $0 100 0.00
2020-06-30 $0 15 0.00